Join the SKOAP Study today.
For more information or to reach a member of the study team, please contact your local clinical trial site.
Welcome to the SKOAP Study
Learn how SKOAP clinical trial participants are helping advance science and improve outcomes in people with Knee OsteoArthritis pain.
What is the SKOAP Study?
The SKOAP Study is a Sequenced strategy for improving outcomes in people with Knee OsteoArthritis Pain (SKOAP). It is a national study, funded by the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®.
SKOAP compares non-opioid pain treatments with the goal of reducing KOA pain and improving function to find out what treatments work best for which patients.
Minimum Requirements for the Study
Be 18 years or older
Be diagnosed with Knee OsteoArthritis (KOA) in at least one of your knees
Experienced pain in that knee for most days in the past 3 months
Willing to travel to one of our 15+ SKOAP Study Locations nationwide
Meeting the above conditions is the initial qualification for the SKOAP Study. Click the link below for next steps.
What is Knee OsteoArthritis (KOA)?
Knee OsteoArthritis (KOA) occurs when the cartilage that cushions your knee joint wears down with time or from trauma.
Is the SKOAP Study Covered by Insurance?
Most insurance companies approve and cover our study procedures. There may be a copay that candidates will be responsible for.
That said, insurance coverage does vary by region and company. For specific questions, call the project coordinator at the closest SKOAP site using the contact information on the About Us page.
SKOAP Study Locations
The SKOAP Study is a multi-site study, coordinated by principal investigators at the Johns Hopkins University in Baltimore, MD.
Fill out the brief qualifying form to pre-qualify and have a study team member contact you, or contact your local clinical trial team to speak directly with a study team member today.